Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro.
Antibacterial effect
Biofilm
Periprosthetic infection
Sphingosine
Journal
Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
07
08
2019
accepted:
18
11
2019
revised:
11
11
2019
pubmed:
22
12
2019
medline:
30
4
2021
entrez:
22
12
2019
Statut:
ppublish
Résumé
Periprosthetic infection (PPI) is a devastating complication in joint replacement surgery. On the background of an aging population, the number of joint replacements and associated complications is expected to increase. The capability for biofilm formation and the increasing resistance of different microbes to antibiotics have complicated the treatment of PPI, requiring the need for the development of alternative treatment options. The bactericidal effect of the naturally occurring amino alcohol sphingosine has already been reported. In our study, we demonstrate the antimicrobial efficacy of sphingosine on three different strains of biofilm producing Staphylococcus epidermidis, representing one of the most frequent microbes involved in PPI. In an in vitro analysis, sphingosine's capability for prevention and treatment of biofilm-contamination on different common orthopedic implant surfaces was tested. Coating titanium implant samples with sphingosine not only prevented implant contamination but also revealed a significant reduction of biofilm formation on the implant surfaces by 99.942%. When testing the antimicrobial efficacy of sphingosine on sessile biofilm-grown Staphylococcus epidermidis, sphingosine solution was capable to eliminate 99.999% of the bacteria on the different implant surfaces, i.e., titanium, steel, and polymethylmethacrylate. This study provides evidence on the antimicrobial efficacy of sphingosine for both planktonic and sessile biofilm-grown Staphylococcus epidermidis on contaminated orthopedic implants. Sphingosine may provide an effective and cheap treatment option for prevention and reduction of infections in joint replacement surgery. KEY MESSAGES: • Here we established a novel technology for prevention of implant colonization by sphingosine-coating of orthopedic implant materials. • Sphingosine-coating of orthopedic implants prevented bacterial colonization and significantly reduced biofilm formation on implant surfaces by 99.942%. • Moreover, sphingosine solution was capable to eliminate 99.999% of sessile biofilm-grown Staphylococcus epidermidis on different orthopedic implant surfaces.
Identifiants
pubmed: 31863153
doi: 10.1007/s00109-019-01858-x
pii: 10.1007/s00109-019-01858-x
pmc: PMC7007894
doi:
Substances chimiques
Anti-Bacterial Agents
0
Polymethacrylic Acids
0
Steel
12597-69-2
polymethacrylic acid
25087-26-7
Titanium
D1JT611TNE
Sphingosine
NGZ37HRE42
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
209-219Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : Gu 335/34-1
Pays : International
Références
Sci Rep. 2017 Dec 15;7(1):17627
pubmed: 29247204
Antimicrob Agents Chemother. 2001 Nov;45(11):3262-6
pubmed: 11600396
J Surg Res. 2017 Nov;219:354-359
pubmed: 29078905
J Invest Dermatol. 1992 Mar;98(3):269-73
pubmed: 1545135
J Clin Invest. 2013 Feb;123(2):666-81
pubmed: 23321671
Skin Pharmacol Physiol. 2013;26(1):36-44
pubmed: 23128426
J Leukoc Biol. 2016 Dec;100(6):1233-1237
pubmed: 27418352
Cell Physiol Biochem. 2016;38(6):2094-102
pubmed: 27184795
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
Acta Derm Venereol. 1993 Dec;73(6):407-11
pubmed: 7906449
Biomaterials. 2008 Dec;29(35):4684-90
pubmed: 18814909
Dtsch Arztebl Int. 2017 May 26;114(20):347-353
pubmed: 28610654
Cell Biol Int. 2016 Oct;40(10):1129-36
pubmed: 27486054
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229
APMIS. 2007 Aug;115(8):891-9
pubmed: 17696944
J Mol Med (Berl). 2019 Aug;97(8):1195-1211
pubmed: 31222488
Antimicrob Agents Chemother. 2012 Mar;56(3):1157-61
pubmed: 22155833
Lancet. 2001 Jul 14;358(9276):135-8
pubmed: 11463434
New Horiz. 1998 May;6(2 Suppl):S3-10
pubmed: 9654307
Int J Oral Sci. 2013 Sep;5(3):130-40
pubmed: 23867843
Cell Host Microbe. 2017 Jun 14;21(6):707-718.e8
pubmed: 28552668
J Bone Joint Surg Br. 2012 Nov;94(11):1455-6
pubmed: 23109621
J Orthop Traumatol. 2015 Mar;16(1):1-7
pubmed: 24821631
Biomaterials. 2016 Apr;84:301-314
pubmed: 26851394
Clin Orthop Relat Res. 2010 Aug;468(8):2046-51
pubmed: 20195808
N Engl J Med. 2004 Apr 1;350(14):1422-9
pubmed: 15070792
Nat Rev Microbiol. 2009 Aug;7(8):555-67
pubmed: 19609257
mBio. 2014 Sep 30;5(5):e01910-14
pubmed: 25271290
Nephrol Dial Transplant. 2009 Jun;24(6):1937-45
pubmed: 19181762
EMBO Mol Med. 2014 Aug 01;6(9):1205-14
pubmed: 25085879
PLoS Pathog. 2014 Jan;10(1):e1003889
pubmed: 24465209
J Bone Joint Surg Br. 2006 Feb;88(2):149-55
pubmed: 16434514
Clin Orthop Relat Res. 2014 Jul;472(7):2197-200
pubmed: 24615421
IUBMB Life. 2014 Mar;66(3):147-155
pubmed: 24638917
J Med Microbiol. 2014 Jun;63(Pt 6):884-91
pubmed: 24667769